DaivaReginaBajorunasMD

Physician

Dr. Bajorunas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

69 citations
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL ...
Christie M. Ballantyne, Michael H. Davidson, James M. McKenney, Laurence H. Keller, Daiva R. Bajorunas
The American Journal of Cardiology. 2008-05-15
32 citations
Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose...
Christie M. Ballantyne, Michael H. Davidson, James M. McKenney, Laurence H. Keller, Daiva R. Bajorunas
Journal of Clinical Lipidology. 2008-04-01
46 citations
Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Richard H. Karas, Moti L. Kashyap, Robert H. Knopp, Laurence H. Keller, Daiva R. Bajorunas
American Journal of Cardiovascular Drugs. 2008-01-01

Araim Pharmaceuticals’ Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of SarcoidosisMay 8th, 2017
Araim Pharmaceuticals Announces a Strategic Partnership with Vault Bioventures to Support Development and Commercialization of ARA 290 as Well as Other Peptides Within a Novel FamilyJanuary 20th, 2016